APO Research
Talk to an analyst

APO RESEARCH · REPORT

Skin Microbiome Modulator

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Skin Microbiome Modulator Market Outlook and Growth Opportunities 2026

22 December 2025198 pages

Choose your research edition.

Industry ResearchSkin Microbiome Modulator Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Skin Microbiome Modulator Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Skin Microbiome Modulator Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Skin Microbiome Modulator Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Skin Microbiome Modulator Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Skin Microbiome Modulator market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Skin Microbiome Modulator is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Skin Microbiome Modulator is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Skin Microbiome Modulator is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Skin Microbiome Modulator market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Skin Microbiome Modulator market include L’Oréal S.A., Unilever, The Estée Lauder Companies, Johnson & Johnson, Revlon, Evelo Biosciences, AOBiome, Azitra and GALLINÉE, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Skin Microbiome Modulator market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Skin Microbiome Modulator and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Skin Microbiome Modulator revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Skin Microbiome Modulator market.

Skin Microbiome Modulator Segment by Company

L’Oréal S.A.

Unilever

The Estée Lauder Companies

Johnson & Johnson

Revlon

Evelo Biosciences

AOBiome

Azitra

GALLINÉE

Glowbiotics

Skin Microbiome Modulator Segment by Type

Probiotics

Prebiotics

Drugs

Skin Microbiome Modulator Segment by Application

Skin Care

Hair Care

Others

Skin Microbiome Modulator Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Skin Microbiome Modulator status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Skin Microbiome Modulator key companies, revenue, market share, and recent developments.

3. To split the Skin Microbiome Modulator breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Skin Microbiome Modulator market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Skin Microbiome Modulator significant trends, drivers, influence factors in global and regions.

6. To analyze Skin Microbiome Modulator competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Skin Microbiome Modulator market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Skin Microbiome Modulator and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Skin Microbiome Modulator.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Skin Microbiome Modulator industry.

Chapter 3: Detailed analysis of Skin Microbiome Modulator company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Skin Microbiome Modulator in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Skin Microbiome Modulator in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Skin Microbiome Modulator Industry Trends Table 2. Skin Microbiome Modulator Industry Drivers Table 3. Skin Microbiome Modulator Industry Opportunities and Challenges Table 4. Skin Microbiome Modulator Industry Restraints Table 5. Global Skin Microbiome Modulator Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Skin Microbiome Modulator Revenue Share by Company (2021-2026) Table 7. Global Skin Microbiome Modulator Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Skin Microbiome Modulator Key Company Manufacturing Base & Headquarters Table 9. Global Skin Microbiome Modulator Company, Product Type & Application Table 10. Global Skin Microbiome Modulator Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Skin Microbiome Modulator by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Probiotics Table 15. Significant Companies of Prebiotics Table 16. Significant Companies of Drugs Table 17. Global Skin Microbiome Modulator Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Skin Microbiome Modulator Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Skin Microbiome Modulator Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Skin Microbiome Modulator Sales Value Share by Type (2021-2026) Table 21. Global Skin Microbiome Modulator Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Skin Care Table 23. Significant Companies of Hair Care Table 24. Significant Companies of Others Table 25. Global Skin Microbiome Modulator Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Skin Microbiome Modulator Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Skin Microbiome Modulator Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Skin Microbiome Modulator Sales Value Share by Application (2021-2026) Table 29. Global Skin Microbiome Modulator Sales Value Share by Application (2027-2032) Table 30. Global Skin Microbiome Modulator Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Skin Microbiome Modulator Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Skin Microbiome Modulator Sales Value Share by Region (2021-2026) Table 33. Global Skin Microbiome Modulator Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Skin Microbiome Modulator Sales Value Share by Region (2027-2032) Table 35. Global Skin Microbiome Modulator Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Skin Microbiome Modulator Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Skin Microbiome Modulator Sales Value Market Share by Country (2021-2026) Table 38. Global Skin Microbiome Modulator Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Skin Microbiome Modulator Sales Value Market Share by Country (2027-2032) Table 40. L’Oréal S.A. Company Information Table 41. L’Oréal S.A. Business Overview Table 42. L’Oréal S.A. Skin Microbiome Modulator Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. L’Oréal S.A. Skin Microbiome Modulator Product Portfolio Table 44. L’Oréal S.A. Recent Development Table 45. Unilever Company Information Table 46. Unilever Business Overview Table 47. Unilever Skin Microbiome Modulator Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Unilever Skin Microbiome Modulator Product Portfolio Table 49. Unilever Recent Development Table 50. The Estée Lauder Companies Company Information Table 51. The Estée Lauder Companies Business Overview Table 52. The Estée Lauder Companies Skin Microbiome Modulator Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. The Estée Lauder Companies Skin Microbiome Modulator Product Portfolio Table 54. The Estée Lauder Companies Recent Development Table 55. Johnson & Johnson Company Information Table 56. Johnson & Johnson Business Overview Table 57. Johnson & Johnson Skin Microbiome Modulator Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Johnson & Johnson Skin Microbiome Modulator Product Portfolio Table 59. Johnson & Johnson Recent Development Table 60. Revlon Company Information Table 61. Revlon Business Overview Table 62. Revlon Skin Microbiome Modulator Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Revlon Skin Microbiome Modulator Product Portfolio Table 64. Revlon Recent Development Table 65. Evelo Biosciences Company Information Table 66. Evelo Biosciences Business Overview Table 67. Evelo Biosciences Skin Microbiome Modulator Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Evelo Biosciences Skin Microbiome Modulator Product Portfolio Table 69. Evelo Biosciences Recent Development Table 70. AOBiome Company Information Table 71. AOBiome Business Overview Table 72. AOBiome Skin Microbiome Modulator Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. AOBiome Skin Microbiome Modulator Product Portfolio Table 74. AOBiome Recent Development Table 75. Azitra Company Information Table 76. Azitra Business Overview Table 77. Azitra Skin Microbiome Modulator Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Azitra Skin Microbiome Modulator Product Portfolio Table 79. Azitra Recent Development Table 80. GALLINÉE Company Information Table 81. GALLINÉE Business Overview Table 82. GALLINÉE Skin Microbiome Modulator Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. GALLINÉE Skin Microbiome Modulator Product Portfolio Table 84. GALLINÉE Recent Development Table 85. Glowbiotics Company Information Table 86. Glowbiotics Business Overview Table 87. Glowbiotics Skin Microbiome Modulator Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Glowbiotics Skin Microbiome Modulator Product Portfolio Table 89. Glowbiotics Recent Development Table 90. Research Programs/Design for This Report Table 91. Authors List of This Report Table 92. Secondary Sources Table 93. Primary Sources List of Figures Figure 1. Skin Microbiome Modulator Product Image Figure 2. Global Skin Microbiome Modulator Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Skin Microbiome Modulator Market Size (2021-2032) & (US$ Million) Figure 4. Global Skin Microbiome Modulator Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Probiotics Image Figure 8. Prebiotics Image Figure 9. Drugs Image Figure 10. Global Skin Microbiome Modulator Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Skin Microbiome Modulator Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Skin Microbiome Modulator Sales Value Share by Type (2021-2032) Figure 13. Skin Care Image Figure 14. Hair Care Image Figure 15. Others Image Figure 16. Global Skin Microbiome Modulator Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Skin Microbiome Modulator Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Skin Microbiome Modulator Sales Value Share by Application (2021-2032) Figure 19. Global Skin Microbiome Modulator Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Skin Microbiome Modulator Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Skin Microbiome Modulator Sales Value (2021-2032) & (US$ Million) Figure 22. North America Skin Microbiome Modulator Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Skin Microbiome Modulator Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Skin Microbiome Modulator Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Skin Microbiome Modulator Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Skin Microbiome Modulator Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Skin Microbiome Modulator Sales Value (2021-2032) & (US$ Million) Figure 28. South America Skin Microbiome Modulator Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Skin Microbiome Modulator Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Skin Microbiome Modulator Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Skin Microbiome Modulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Skin Microbiome Modulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Skin Microbiome Modulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Skin Microbiome Modulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Skin Microbiome Modulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Skin Microbiome Modulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Skin Microbiome Modulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Skin Microbiome Modulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Skin Microbiome Modulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Skin Microbiome Modulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Skin Microbiome Modulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Skin Microbiome Modulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Skin Microbiome Modulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Skin Microbiome Modulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Skin Microbiome Modulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Skin Microbiome Modulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Skin Microbiome Modulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Skin Microbiome Modulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Skin Microbiome Modulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Skin Microbiome Modulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Skin Microbiome Modulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Skin Microbiome Modulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Skin Microbiome Modulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Skin Microbiome Modulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Skin Microbiome Modulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Skin Microbiome Modulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Skin Microbiome Modulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Skin Microbiome Modulator Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Probiotics
  • Prebiotics
  • Drugs
Applications
  • Skin Care
  • Hair Care
  • Others
Companies covered
  • L’Oréal S.A.
  • Unilever
  • The Estée Lauder Companies
  • Johnson & Johnson
  • Revlon
  • Evelo Biosciences
  • AOBiome
  • Azitra
  • GALLINÉE
  • Glowbiotics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Skin Microbiome Modulator Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Skin Microbiome Modulator Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Skin Microbiome Modulator Market Dynamics
  1. 2.1 Skin Microbiome Modulator Industry Trends
  2. 2.2 Skin Microbiome Modulator Industry Drivers
  3. 2.3 Skin Microbiome Modulator Industry Opportunities and Challenges
  4. 2.4 Skin Microbiome Modulator Industry Restraints
3 Skin Microbiome Modulator Market by Company
  1. 3.1 Global Skin Microbiome Modulator Company Revenue Ranking in 2025
  2. 3.2 Global Skin Microbiome Modulator Revenue by Company (2021-2026)
  3. 3.3 Global Skin Microbiome Modulator Company Ranking (2024-2026)
  4. 3.4 Global Skin Microbiome Modulator Company Manufacturing Base and Headquarters
  5. 3.5 Global Skin Microbiome Modulator Company Product Type and Application
  6. 3.6 Global Skin Microbiome Modulator Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Skin Microbiome Modulator Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Skin Microbiome Modulator Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Skin Microbiome Modulator Market by Type
  1. 4.1 Skin Microbiome Modulator Type Introduction
  2. 4.1.1 Probiotics
  3. 4.1.2 Prebiotics
  4. 4.1.3 Drugs
  5. 4.2 Global Skin Microbiome Modulator Sales Value by Type
  6. 4.2.1 Global Skin Microbiome Modulator Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Skin Microbiome Modulator Sales Value by Type (2021-2032)
  8. 4.2.3 Global Skin Microbiome Modulator Sales Value Share by Type (2021-2032)
5 Skin Microbiome Modulator Market by Application
  1. 5.1 Skin Microbiome Modulator Application Introduction
  2. 5.1.1 Skin Care
  3. 5.1.2 Hair Care
  4. 5.1.3 Others
  5. 5.2 Global Skin Microbiome Modulator Sales Value by Application
  6. 5.2.1 Global Skin Microbiome Modulator Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Skin Microbiome Modulator Sales Value by Application (2021-2032)
  8. 5.2.3 Global Skin Microbiome Modulator Sales Value Share by Application (2021-2032)
6 Skin Microbiome Modulator Regional Value Analysis
  1. 6.1 Global Skin Microbiome Modulator Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Skin Microbiome Modulator Sales Value by Region (2021-2032)
  3. 6.2.1 Global Skin Microbiome Modulator Sales Value by Region: 2021-2026
  4. 6.2.2 Global Skin Microbiome Modulator Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Skin Microbiome Modulator Sales Value (2021-2032)
  7. 6.3.2 North America Skin Microbiome Modulator Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Skin Microbiome Modulator Sales Value (2021-2032)
  10. 6.4.2 Europe Skin Microbiome Modulator Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Skin Microbiome Modulator Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Skin Microbiome Modulator Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Skin Microbiome Modulator Sales Value (2021-2032)
  16. 6.6.2 South America Skin Microbiome Modulator Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Skin Microbiome Modulator Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Skin Microbiome Modulator Sales Value Share by Country, 2025 VS 2032
7 Skin Microbiome Modulator Country-level Value Analysis
  1. 7.1 Global Skin Microbiome Modulator Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Skin Microbiome Modulator Sales Value by Country (2021-2032)
  3. 7.2.1 Global Skin Microbiome Modulator Sales Value by Country (2021-2026)
  4. 7.2.2 Global Skin Microbiome Modulator Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Skin Microbiome Modulator Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Skin Microbiome Modulator Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Skin Microbiome Modulator Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Skin Microbiome Modulator Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Skin Microbiome Modulator Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Skin Microbiome Modulator Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Skin Microbiome Modulator Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Skin Microbiome Modulator Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Skin Microbiome Modulator Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Skin Microbiome Modulator Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Skin Microbiome Modulator Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Skin Microbiome Modulator Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Skin Microbiome Modulator Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Skin Microbiome Modulator Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Skin Microbiome Modulator Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Skin Microbiome Modulator Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Skin Microbiome Modulator Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Skin Microbiome Modulator Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Skin Microbiome Modulator Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Skin Microbiome Modulator Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Skin Microbiome Modulator Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Skin Microbiome Modulator Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Skin Microbiome Modulator Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Skin Microbiome Modulator Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Skin Microbiome Modulator Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Skin Microbiome Modulator Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Skin Microbiome Modulator Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Skin Microbiome Modulator Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Skin Microbiome Modulator Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Skin Microbiome Modulator Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 L’Oréal S.A.
  2. 8.1.1 L’Oréal S.A. Company Information
  3. 8.1.2 L’Oréal S.A. Business Overview
  4. 8.1.3 L’Oréal S.A. Skin Microbiome Modulator Revenue and Gross Margin (2021-2026)
  5. 8.1.4 L’Oréal S.A. Skin Microbiome Modulator Product Portfolio
  6. 8.1.5 L’Oréal S.A. Recent Developments
  7. 8.2 Unilever
  8. 8.2.1 Unilever Company Information
  9. 8.2.2 Unilever Business Overview
  10. 8.2.3 Unilever Skin Microbiome Modulator Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Unilever Skin Microbiome Modulator Product Portfolio
  12. 8.2.5 Unilever Recent Developments
  13. 8.3 The Estée Lauder Companies
  14. 8.3.1 The Estée Lauder Companies Company Information
  15. 8.3.2 The Estée Lauder Companies Business Overview
  16. 8.3.3 The Estée Lauder Companies Skin Microbiome Modulator Revenue and Gross Margin (2021-2026)
  17. 8.3.4 The Estée Lauder Companies Skin Microbiome Modulator Product Portfolio
  18. 8.3.5 The Estée Lauder Companies Recent Developments
  19. 8.4 Johnson & Johnson
  20. 8.4.1 Johnson & Johnson Company Information
  21. 8.4.2 Johnson & Johnson Business Overview
  22. 8.4.3 Johnson & Johnson Skin Microbiome Modulator Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Johnson & Johnson Skin Microbiome Modulator Product Portfolio
  24. 8.4.5 Johnson & Johnson Recent Developments
  25. 8.5 Revlon
  26. 8.5.1 Revlon Company Information
  27. 8.5.2 Revlon Business Overview
  28. 8.5.3 Revlon Skin Microbiome Modulator Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Revlon Skin Microbiome Modulator Product Portfolio
  30. 8.5.5 Revlon Recent Developments
  31. 8.6 Evelo Biosciences
  32. 8.6.1 Evelo Biosciences Company Information
  33. 8.6.2 Evelo Biosciences Business Overview
  34. 8.6.3 Evelo Biosciences Skin Microbiome Modulator Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Evelo Biosciences Skin Microbiome Modulator Product Portfolio
  36. 8.6.5 Evelo Biosciences Recent Developments
  37. 8.7 AOBiome
  38. 8.7.1 AOBiome Company Information
  39. 8.7.2 AOBiome Business Overview
  40. 8.7.3 AOBiome Skin Microbiome Modulator Revenue and Gross Margin (2021-2026)
  41. 8.7.4 AOBiome Skin Microbiome Modulator Product Portfolio
  42. 8.7.5 AOBiome Recent Developments
  43. 8.8 Azitra
  44. 8.8.1 Azitra Company Information
  45. 8.8.2 Azitra Business Overview
  46. 8.8.3 Azitra Skin Microbiome Modulator Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Azitra Skin Microbiome Modulator Product Portfolio
  48. 8.8.5 Azitra Recent Developments
  49. 8.9 GALLINÉE
  50. 8.9.1 GALLINÉE Company Information
  51. 8.9.2 GALLINÉE Business Overview
  52. 8.9.3 GALLINÉE Skin Microbiome Modulator Revenue and Gross Margin (2021-2026)
  53. 8.9.4 GALLINÉE Skin Microbiome Modulator Product Portfolio
  54. 8.9.5 GALLINÉE Recent Developments
  55. 8.10 Glowbiotics
  56. 8.10.1 Glowbiotics Company Information
  57. 8.10.2 Glowbiotics Business Overview
  58. 8.10.3 Glowbiotics Skin Microbiome Modulator Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Glowbiotics Skin Microbiome Modulator Product Portfolio
  60. 8.10.5 Glowbiotics Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst